Dr. Sangeetha Seshadri, MD

Dr. Seshadri practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Seshadri's NPI, 1720395387, was assigned on September 2, 2010. Dr. Seshadri holds New York license 257337.

Dr. Seshadri's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Seshadri's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Seshadri is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Seshadri to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seshadri practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Seshadri's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Seshadri is licensed in New York.

CMS data shows 2,560 Medicare services from Dr. Seshadri across 9 procedure codes in 2024, for 134 Medicare patients. Medicare paid $72,126 for them. Every service was in an office.

CMS counts 134 Medicare patients who saw Dr. Seshadri in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Seshadri's median patient age at 64, with 80% women.

In 2024, Dr. Seshadri wrote 645 Medicare Part D claims for 138 patients. 92% of them were for generic drugs. CMS names the drug for 562 of them, across 13 drugs with 11 or more claims each, at $73,024 in total drug cost. In 2023, CMS named 401 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Seshadri for performance year 2024, reported through an alternative payment model (APM). Dr. Seshadri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seshadri as offering telehealth.

Dmand AI links 1 paper to Dr. Seshadri in 2013. Dr. Seshadri's most frequent co-authors are Elise Belilos, MD and Steven Eric Carsons, MD.

CMS Open Payments shows 120 general payments to Dr. Seshadri from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Abbvie Inc. paid the most, $16,317.